BioVersys Reports Corporate Highlights and Key Financials for the Full Year 2024
Full Year 2024 Conference Call & Audio Webcast BioVersys will host a conference call and webcast at 2:00 PM CET to discuss the financial results, provide an update on the company’s performance, ...
U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine
The inquiry is looking into a politically explosive suggestion that Pfizer delayed announcing a successful vaccine against ...
ETX Daily Up on MSN16h
"Crucial Milestone": US Approves New Antibiotic For Urinary Tract Infections
The product -- called Blujepa -- was approved for the treatment of uncomplicated urinary tract infections in adult women and ...
BIOVERSYS REPORTS CORPORATE HIGHLIGHS AND KEY FINANCIALS FOR THE FULL YEAR 2024
March 26, 2025, 7am CET BioVersys AG (SIX: BIOV), a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious ...
Teeth Whitening Market Projected to Hit USD 12.03 Billion by 2032 – SNS Insider
According to Research by SNS Insider, the global Teeth Whitening Market growth is fueled by rising aesthetic consciousness and advancements in whitening technology.Pune, March 26, 2025 (GLOBE NEWSWIRE ...